Tretinoin Market 2019, Global Industry Analysis, Size, Share, Growth, Trends and Forecast – 2024 adds “Tretinoin Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database

PUNE, MAHARASHTRA, INDIA, March 15, 2019 / — Summary adds “Tretinoin Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.

This report provides in depth study of “Tretinoin Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Tretinoin Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Tretinoin is the pharmaceutical form of retinoic acid. One of several retinoids, it is the carboxylic acid form of vitamin A and is also known as all-trans retinoic acid (ATRA). It is a first generation topical retinoid commonly used topically to treat acne vulgaris. It is also used orally to treat acute promyelocytic leukemia (APL). Its isomer, isotretinoin, is also an acne drug. It is on the World Health Organization’s List of Essential Medicines, a list of the most important medications needed in a basic health system.
Market Segment by Manufacturers, this report covers BASF, LGM Pharma, GF Health, Gyma Laboratories, Genemed Synthesis, IMCoPharma, Chongqing Huabang, Olon S.p.A., Sun Pharma.
The global Tretinoin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tretinoin market based on company, product type, end user and key regions.

This report studies the global market size of Tretinoin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tretinoin in these regions.
This research report categorizes the global Tretinoin market by top players/brands, region, type and end user. This report also studies the global Tretinoin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
LGM Pharma
GF Health
Gyma Laboratories
Genemed Synthesis
Chongqing Huabang
Olon S.p.A.
Sun Pharma.

Request a Sample Report @

Market size by Product
0.1% Tretinoin
0.02% Tretinoin
0.025% Tretinoin
0.05% Tretinoin
Market size by End User
Skin Use

Market size by Region
North America
United States
South Korea
Central & South America
Rest of Central & South America
Middle East & Africa
GCC Countries
South Africa

At any Query @

Major Key Points in Table of Content

1 Study Coverage
1.1 Tretinoin Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tretinoin Market Size Growth Rate by Product
1.4.2 0.1% Tretinoin
1.4.3 0.02% Tretinoin
1.4.4 0.025% Tretinoin
1.4.5 0.05% Tretinoin
1.5 Market by End User
1.5.1 Global Tretinoin Market Size Growth Rate by End User
1.5.2 Skin Use
1.5.3 Leukemia
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Tretinoin Market Size
2.1.1 Global Tretinoin Revenue 2014-2025
2.1.2 Global Tretinoin Sales 2014-2025
2.2 Tretinoin Growth Rate by Regions
2.2.1 Global Tretinoin Sales by Regions
2.2.2 Global Tretinoin Revenue by Regions


11 Company Profiles
11.1 BASF
11.1.1 BASF Company Details
11.1.2 Company Business Overview
11.1.3 BASF Tretinoin Sales, Revenue and Gross Margin (2014-2019)
11.1.4 BASF Tretinoin Products Offered
11.1.5 BASF Recent Development
11.2 LGM Pharma
11.2.1 LGM Pharma Company Details
11.2.2 Company Business Overview
11.2.3 LGM Pharma Tretinoin Sales, Revenue and Gross Margin (2014-2019)
11.2.4 LGM Pharma Tretinoin Products Offered
11.2.5 LGM Pharma Recent Development
11.3 GF Health
11.3.1 GF Health Company Details
11.3.2 Company Business Overview
11.3.GF Health Tretinoin Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GF Health Tretinoin Products Offered
11.3.5 GF Health Recent Development
11.4 Gyma Laboratories
11.4.1 Gyma Laboratories Company Details
11.4.2 Company Business Overview
11.4.3 Gyma Laboratories Tretinoin Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Gyma Laboratories Tretinoin Products Offered
11.4.5 Gyma Laboratories Recent Development
11.5 Genemed Synthesis
11.5.1 Genemed Synthesis Company Details
11.5.2 Company Business Overview
11.5.3 Genemed Synthesis Tretinoin Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Genemed Synthesis Tretinoin Products Offered
11.5.5 Genemed Synthesis Recent Development
11.6 IMCoPharma
11.6.1 IMCoPharma Company Details
11.6.2 Company Business Overview
11.6.3 IMCoPharma Tretinoin Sales, Revenue and Gross Margin (2014-2019)
11.6.4 IMCoPharma Tretinoin Products Offered
11.6.5 IMCoPharma Recent Development
11.7 Chongqing Huabang
11.7.1 Chongqing Huabang Company Details
11.7.2 Company Business Overview
11.7.3 Chongqing Huabang Tretinoin Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Chongqing Huabang Tretinoin Products Offered
11.7.5 Chongqing Huabang Recent Development
11.8 Olon S.p.A.
11.8.1 Olon S.p.A. Company Details
11.8.2 Company Business Overview
11.8.3 Olon S.p.A. Tretinoin Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Olon S.p.A. Tretinoin Products Offered
11.8.5 Olon S.p.A. Recent Development
11.9 Sun Pharma.
11.9.1 Sun Pharma. Company Details
11.9.2 Company Business Overview
11.9.3 Sun Pharma. Tretinoin Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sun Pharma. Tretinoin Products Offered
11.9.5 Sun Pharma. Recent Development

Buy NOW @


Contact Us:

Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)

646-845-9349 (US), +44 208 133 9349 (UK)
email us here
["facebook", "twitter", "google", "linkedin"]
{"facebook"=>"", "twitter"=>"", "google"=>"", "linkedin"=>""}

Source: EIN Presswire